BetterLife Pharma Inc. revealed early positive in vitro results of its proprietary inhaled interferon alpha-2b product, AP-00, from a preclinical study at Dr Stephen Barr's Lab at the ImPaKT Facility, at the Schulich School of Medicine and Dentistry, in Western University, Ontario.  The Vancouver, British Columbia-bas
Full Story >>
Vote
+17